1. Market Research
  2. > Pharmaceutical
  3. > Therapy Market Trends
Bronchodilators Market by Drug class, by Indication, and Route of Administration : Global Opportunity Analysis and Industry Forecast, 2019–2026

Bronchodilators Market by Drug class, by Indication, and Route of Administration : Global Opportunity Analysis and Industry Forecast, 2019–2026

  • February 2020
  • 207 pages
  • ID: 5889557
  • Format: PDF
  • Allied Market Research

Summary

Table of Contents

Bronchodilators Market by Drug class (Sympathomimetics, Anticholinergics, Phosphodiesterase Inhibitor and Combination Drugs), by Indication (Asthma, COPD, and Others), and Route of Administration (Oral, Injection, and Inhaler): Global Opportunity Analysis and Industry Forecast, 2019–2026

The global bronchodilators market was valued at $27,580.00 million in 2018 and is expected to reach $41,487.53 million by 2026, registering a CAGR of 5.2% from 2019 to 2026. Bronchodilators are drugs that relax muscles that tighten around the airways. These drugs open airways and allow more air to move in and out of lungs. They are also used to reduce mucus from lungs. Patients suffering from respiratory disorders consume these drugs through the help of nebulizers or inhalers. In addition, inhaler bronchodilators have effects on mucociliary clearance as well. Bronchodilators are used in the treatment of obstructive lung diseases by relaxing the lung muscles and widening the airways (bronchi). They are used in the treatment of asthma and chronic obstructive pulmonary diseases (COPD).

Surge in prevalence of respiratory disorders such as asthma, chronic obstructive pulmonary disease (COPD) across the globe is the major factor driving the bronchodilators market growth. Other factors such as rise in incidence of respiratory diseases due to cigarette smoking also boost the market growth. In addition, rise in disposable income, geriatric population, and increase in awareness for healthcare among people are anticipated to boost the market growth. However, side effects associated with bronchodilators and government regulations related to the safety & efficacy of these drugs are anticipated to hamper the market growth. Furthermore, ongoing R&D activities related to bronchodilators are anticipated to present new opportunities for the market.

The market is segmented on the basis of indication, drug type, route of administration, and region. On the basis of indication, it is categorized into asthma, chronic obstructive pulmonary disease (COPD), and others. By drug type, it is classified into sympathomimetics, anticholinergics, phosphodiesterase inhibitors, and combination drugs. On the basis of route of administration, it is categorized into oral, injection, and inhaler. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Comprehensive competitive analysis and profiles of major market players such as AstraZeneca, Boehringer Ingelheim, GlaxoSmithKline, Hoffmann-La Roche, AstraZeneca plc, Novartis AG, Pfizer Inc., Teva Pharmaceutical Industries Ltd., Vectura Group plc., and Abbott Laboratories are provided in this report.

KEY BENEFITS FOR STAKEHOLDERS

- The study provides an in-depth analysis of the market along with the current trends and future estimations to elucidate the imminent investment pockets.

- It offers a quantitative analysis from 2018 to 2026, which is expected to enable the stakeholders to capitalize on prevailing market opportunities.

- Comprehensive analysis of all geographical regions is provided to determine the prevailing opportunities.

- Key players are profiled, and their strategies are analyzed thoroughly to understand the competitive outlook of the global market.

KEY MARKET SEGMENTS

By Indication

• Asthma

• Chronic obstructive pulmonary disease (COPD)

• Others

By Drug Type

• Sympathomimetics

• Anticholinergics

• Phosphodiesterase Inhibitor

• Combination Drugs

By Route of Administration

• Oral

• Injection

• Inhaler

By Region

• North America

o U.S.

o Canada

o Mexico

• Europe

o Germany

o France

o UK

o Italy

o Spain

o Rest of Europe

• Asia Pacific

o Japan

o China

o India

o Rest of Asia-Pacific

• LAMEA

o Brazil

o Saudi Arabia

o South Africa

o Rest of LAMEA

LIST OF KEY PLAYERS PROFILED IN THE REPORT

• Boehringer Ingelheim

• GlaxoSmithKline

• F. Hoffmann-La Roche AG

• AstraZeneca plc

• Novartis AG

• Pfizer Inc.

• Teva Pharmaceutical Industries Ltd

• Vectura Group plc.

• Abbott Laboratories

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 150+ Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.
Ahmad helps you find the right report:
Testimonials

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at
Ikea

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at
Ingredion

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

FAQ
  • How we can help
    • I am not sure if the report I am interested in will fulfill my needs. Can you help me?
    • Yes, of course. You can call us at +33(0) 4 37 65 17 03 or drop us an email at researchadvisor@reportlinker.com to let us know more about your requirements.
    • We buy reports often - can ReportLinker get me any benefits?
    • Yes. Set up a call with a Senior Research Advisor to learn more - researchadvisor@reportlinker.com or +33(0) 4 37 65 17 03.
    • I have had negative experiences with market research reports before. How can you avoid this from happening again?
    • We advise all clients to read the TOC and Summary and list your questions so that we can get more insight for you before you make any purchase decision. A research advisor will accompany you so that you can compare samples and reports from different sources, and choose the study that is right for you.

  • Report Delivery
    • How and when I will receive my Report?
    • Most reports are delivered right away in a pdf format, while others are accessed via a secure link and access codes. Do note that sometimes reports are sent within a 12 hour period, depending on the time zones. However, you can contact us to escalate this. Should you need a hard copy, you can check if this option is offered for the particular report, and pay the related fees.
  • Payment conditions
    • What payment methods do you accept?
      1. Credit card : VISA, American Express, Mastercard, or
      2. You can download an invoice to pay by wire transfer, check, or via a Purchase Order from your company, or
      3. You can pay via a Check made out in US Dollars, Euros, or British Pounds for the full amount made payable to ReportLinker
    • What are ReportLinker’s Payment Terms?
    • All payments must normally be submitted within 30 days. However, you can let us know if you need extended time.
    • Are Taxes and duties included?
    • All companies based in France must pay a 20% tax per report. The same applies to all individuals based in the EU. All EU companies must supply their VAT number when purchasing to avoid this charge.
    • I’m not satisfied. Can I be refunded?
    • No. Once your order has been processed and the publisher has received a notification to send you the report, we cannot issue any refund or cancel any order. As these are not ‘traditional’ products that can be returned, reports that are dispatched are considered to be ‘consumed’.
  • User license
    • The license that you should acquire depends on the number of persons that need to access the report. This can range from Single User (only one person will have the right to read or access the report), or Department License (up to 5 persons), to Site License (a group of persons based in the same company location), or Corporate License (the entire company personnel based worldwide). However, as publishers have different terms and conditions, we can look into this for you.
Purchase Reports From Reputable Market Research Publishers

Respiratory Drugs Markets in China

  • $ 4000
  • June 2020
  • 213 pages

China’s demand for Respiratory Drugs has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high speed growth ...


ref:plp2020

Reportlinker.com © Copyright 2020. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on